@FierceBiotech: Will $1B cancer IP theft suit trigger tighter vigilance on researchers' work? Article | Follow @FierceBiotech
@JohnCFierce: So does BioLineRx see itself as a hep C co. now that it has in-licensed a 2nd program, or is this about share price? Release | Follow @JohnCFierce
@FierceMedDev: DNA-sequencing penetrates Norway's healthcare system. Story | Follow @FierceMedDev
@MarkHFierce: Dudes, eat lots of walnuts and your prostate cancer risk may shrink. It worked in mice, at least... More | Follow @MarkHFierce
> When Israel's BioLineRx announced a recent deal to in-license a preclinical hepatitis C drug from Genoscience, its shares soared on speculation that the move put the company in line for a potential takeover. This morning the biotech reported that it in-licensed a second preclinical hepatitis C drug from the same company, and its shares rocketed up 34%. And that is likely to underscore feelings among many that hep C stocks are becoming notoriously volatile. Release
> Anacor shares ($ANAC) tanked this morning after it announced that its partner GlaxoSmithKline ($GSK) had suspended four studies of GSK2251052, an anti-infection treatment. The suspension was triggered by a microbiological finding in some patients. Story
> Albion Ventures and Solon Ventures are injecting $2.4 million into Xceleron, a move that will help pay for the relocation of senior analytics staff to a new facility in Germantown, MD. Some of those staffers are coming from the U.K. Release
Pharma News
@FiercePharma: Could be big if it actually ends up working. RT @FierceMedDev: Depression diagnostic passes initial trial. Story | Follow @FiercePharma
IT News
> Researchers create software-based 3-D genome map. Story
> Supercomputing supports genetic, cancer research in Arizona. Article
> Median Technologies, Sanofi sign medical imaging deal. News
> Norway's sequencing project will need major IT infrastructure. More
> Oracle announces new round of projects in IT, clinical trials. Piece
Medical Device News
> Apollo Endosurgery secures $47.6M to launch surgical tools. News
> GAO report finds some hospitals paying more for devices. Report
> Smith & Nephew, Kensey Nash impress with earnings announcements. Article
> DNA-sequencing penetrates Norway's healthcare system. Story
> ALung scores $10M in Series B. News
And Finally... Investigators concluded that mesenchymal stem cells respond to exercise, which may help point to new treatments for muscle damage. Release